Testing a new insulin pump for adults with type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a new automated insulin pump system (NMX8) for adults with type 1 diabetes whose blood sugar is not well controlled (HbA1c above 7.5%). You must already be using a similar pump system. The goal is to see if this new device can help you get better control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had type 1 diabetes for at least 6 months.
- You are currently using an approved automated insulin pump system (like MiniMed 780G, Control IQ, Omnipod 5, or CamAPS FX) for at least 3 months.
- Your average blood sugar (HbA1c) is above 7.5%, meaning your diabetes is not as well controlled as it could be.
- You use between 6 and 250 units of insulin per day.
- You are willing to switch to a new insulin pump and follow all training sessions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This study tests a new hybrid closed-loop system (an automated insulin pump) in people with type 1 diabetes whose blood sugar is not well controlled. It aims to see if the system is safe and helps improve glucose levels.
This study tests a new experimental automated insulin delivery system for people with type 1 or type 2 diabetes who already use a specific insulin pump (MiniMed 780G with Simplera Sync sensor). The goal is to see if the new system is safe and works well to help manage blood sugar.
This study tests a new automated insulin delivery system (a pump that helps manage blood sugar) in children and adults with diabetes. It aims to see if the system is safe and easy to use in daily life.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a new insulin pump system (MiniMed 780G) in children aged 7-17 who were recently diagnosed with type 1 diabetes. It aims to see if this pump helps control blood sugar better and improves quality of life compared to standard insulin shots or older pumps.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.